ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 146 filers reported holding ROIVANT SCIENCES LTD in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,742,704 | +15.9% | 1,690,300 | 0.0% | 0.36% | +23.3% |
Q2 2023 | $17,038,224 | +36.6% | 1,690,300 | 0.0% | 0.29% | +25.8% |
Q1 2023 | $12,474,414 | -7.6% | 1,690,300 | 0.0% | 0.23% | -13.9% |
Q4 2022 | $13,505,497 | +153.4% | 1,690,300 | 0.0% | 0.27% | +153.3% |
Q3 2022 | $5,330,000 | -20.9% | 1,690,300 | 0.0% | 0.10% | -27.1% |
Q2 2022 | $6,738,000 | -17.6% | 1,690,300 | 0.0% | 0.14% | +12.5% |
Q1 2022 | $8,177,000 | +22.0% | 1,690,300 | +141.5% | 0.13% | +48.8% |
Q4 2021 | $6,703,000 | – | 700,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VI Management, LLC | 1,119,489 | $8,261,829 | 96.90% |
Two Seas Capital LP | 7,807,107 | $57,616,450 | 52.88% |
QVT Financial LP | 122,541,536 | $904,356,536 | 44.47% |
Patient Square Capital LP | 6,825,967 | $50,375,636 | 40.49% |
Whitefort Capital Management, LP | 833,471 | $6,151,016 | 5.72% |
Anchorage Capital Group, L.L.C. | 4,832,642 | $35,664,898 | 5.51% |
SB INVESTMENT ADVISERS (UK) LTD | 83,031,667 | $612,773,702 | 5.04% |
Octagon Capital Advisors LP | 3,904,000 | $28,811,520 | 4.14% |
VIKING GLOBAL INVESTORS LP | 88,238,700 | $651,201,606 | 3.06% |
HSG Holding Ltd | 3,897,193 | $28,761,284 | 3.02% |